2020
DOI: 10.1080/07391102.2020.1777899
|View full text |Cite
|
Sign up to set email alerts
|

Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Based on molecular docking, molecular dynamics simulations were used to further investigate the conformational changes during the binding of the major compounds to the active protein. The RMSD method was used to determine the average deviation of the ligand-enzyme receptor conformation within 50 ns thus assessing the steady state of the ligand-receptor system [ 57 ]. Figure 7 A shows that the RMSD values of the (+)-catechin-tyrosinase system and (−)-epicatechin-tyrosinase system exhibited an increasing trend at first, then decreased and finally reached the basic equilibrium during 50 ns, indicating that the ligand is bound to the active site of tyrosinase and the whole system was stable.…”
Section: Resultsmentioning
confidence: 99%
“…Based on molecular docking, molecular dynamics simulations were used to further investigate the conformational changes during the binding of the major compounds to the active protein. The RMSD method was used to determine the average deviation of the ligand-enzyme receptor conformation within 50 ns thus assessing the steady state of the ligand-receptor system [ 57 ]. Figure 7 A shows that the RMSD values of the (+)-catechin-tyrosinase system and (−)-epicatechin-tyrosinase system exhibited an increasing trend at first, then decreased and finally reached the basic equilibrium during 50 ns, indicating that the ligand is bound to the active site of tyrosinase and the whole system was stable.…”
Section: Resultsmentioning
confidence: 99%
“…EGFR is also a well-known curative target for TNBC. 28 , 29 Similarly, Livasy reported that 70–78% of patients with TNBC highly express EGFR. Hence, EGFR might be a possible therapeutic target in TNBC.…”
Section: Discussionmentioning
confidence: 99%
“…Then, the refined target structure was taken into Glide receptor grid generation panel for the generation of the three-dimensional (3D) grid box with a size of 20 × 20 × 20 Å with van der Waals scaling factor set at 1.0 and partial charge cut-off at 0.25. A total of 300,000 compounds were downloaded from Zinc database in the form of SDF and the compounds structure were imported into ligprep panel and preparation was performed [12,13]. Here we applied some crucial criteria for ligand preparation including i) Ligands ionization points at pH 7.0 ± 2.0 and the stereoisomers were generated for each ligand structure, ii) compounds structural energy minimization using the OPLS3 force field, (iii) the desalt-option were generated, (iv) tautomer were generated for all conformers, (v) one lowest energy conformer was generated per ligand.…”
Section: Virtual Screeningmentioning
confidence: 99%